# Protea Biosciences Group, Inc.

Protea Biosciences Group, Inc. is a company headquartered in Morgantown, WV, United States.

## Company overview

- **Legal name:** Protea Biosciences Group, Inc.
- **Former names in filing history:** Protea Biosciences Inc. (2011-09-08 to 2011-09-09); SRKP 5 INC (2005-08-03 to 2011-08-19)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Morgantown, WV, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001335103

## About

Protea Biosciences Group, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001335103, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2017-04-14, it reported annual revenue of USD 2,446,795; net income of USD -15,647,922; total assets of USD 3,214,090 for the fiscal period ended 2016-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2016 (period ended 2016-12-31)

- **Revenue:** $2.4M (USD 2,446,795)
- **Net income:** -$15.6M (USD -15,647,922)
- **Total assets:** $3.2M (USD 3,214,090)
- **Cash and equivalents:** $78,720 (USD 78,720)

### FY2015 (period ended 2015-12-31)

- **Revenue:** $2.0M (USD 2,003,286)
- **Net income:** -$9.6M (USD -9,574,434)
- **Total assets:** $3.0M (USD 3,043,746)
- **Cash and equivalents:** $6,450 (USD 6,450)
- **Later filings:** Revenue: shown as originally filed; later filings report different values for the same periods.

### FY2014 (period ended 2014-12-31)

- **Revenue:** $1.8M (USD 1,768,312)
- **Net income:** -$11.5M (USD -11,474,770)
- **Total assets:** $4.0M (USD 4,028,127)
- **Cash and equivalents:** $322,877 (USD 322,877)

### FY2013 (period ended 2013-12-31)

- **Revenue:** $1.2M (USD 1,223,492)
- **Net income:** -$11.4M (USD -11,417,670)
- **Total assets:** $5.4M (USD 5,417,927)
- **Cash and equivalents:** $1.1M (USD 1,086,330)
- **Operating cash flow:** -$10.2M (USD -10,220,818)

## Recent SEC filings

- Form 8-K — filed 2017-12-05 — period 2017-12-01 — FORM 8-K
- Form 8-K — filed 2017-12-01 — period 2017-11-27 — FORM 8-K
- Form 8-K — filed 2017-11-13 — period 2017-11-07 — 8-K
- Form 8-K — filed 2017-10-26 — period 2017-10-20 — FORM 8-K
- Form 8-K — filed 2017-10-16 — period 2017-10-13 — FORM 8-K
- Form 8-K — filed 2017-10-04 — period 2017-10-03 — FORM 8-K
- Form 8-K — filed 2017-09-29 — period 2017-09-29 — 8-K
- Form S-1 — filed 2017-08-29 — S-1
- Form 8-K — filed 2017-08-25 — period 2017-08-25 — 8-K
- Form 10-Q — filed 2017-08-18 — period 2017-06-30 — FORM 10-Q
- Form 8-K — filed 2017-06-28 — period 2017-06-09 — 8-K
- Form 10-Q — filed 2017-05-19 — period 2017-03-31 — FORM 10-Q

---

Updated: 2026-10-23T20:06:36Z

Canonical page: https://altss.com/profile/protea-biosciences-group-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology